Financials • Investment Bankers/Brokers/Service
$3.47 ▼ -0.10
(-2.80%)
MKT CAP: $1.31B • VOL: 2.39M
52W L $3 52W H $6
ROARABLE / RQD
C+ • 66/100
PIOTROSKI
5 / 9
UROY // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-04-30 | FY 2024
FILED 2025-04-30 | FY 2023
FILED 2024-04-30 |
|---|---|---|---|
| Revenue (Total Sales) | $0 | $0 | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $48.3M | -$3.4M | $5.1M |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | $40.2M | -$4.5M | $13.7M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $178.5M | -$15.1M | -$76.4M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $178.5M | -$15.1M | -$76.4M |
| FCF Margin % | — | — | — |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | — | — | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR UROY.